![Mark W. Womack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark W. Womack
Amministratore Delegato presso
Selexis SA
Profilo
Mark W.
Womack is currently Chief Executive Officer at Selexis SA since 2022.
Formerly, Mr. Womack was Chief Executive Officer at KBI Biopharma, Inc. from 2022 to 2023, Chief Executive Officer at OneSource Specialty Pharma Ltd., Chief Executive Officer at BioCina Pty Ltd. from 2023 to 2025, and Chief Business Officer at AGC Biologics, Inc.
Posizioni attive di Mark W. Womack
| Società | Posizione | Inizio |
|---|---|---|
Selexis SA
 Selexis SA Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the field of mammalian cell lines | Amministratore Delegato | 02/05/2022 |
Precedenti posizioni note di Mark W. Womack
| Società | Posizione | Fine |
|---|---|---|
KBI Biopharma, Inc.
 KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Amministratore Delegato | 17/04/2023 |
| ONESOURCE SPECIALTY PHARMA LIMITED | Amministratore Delegato | - |
AGC Biologics, Inc.
 AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures protein-based therapeutics | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
2
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Commercial Services |
AGC Biologics, Inc.
AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures protein-based therapeutics | Health Technology |
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the field of mammalian cell lines | Commercial Services |
OneSource Specialty Pharma Ltd.
 OneSource Specialty Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures GLP-1 drugs & novel biologics | Health Technology |
